Note 14 - Segment Information

12 Months Ended

Jun. 30, 2014

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

Note 14. Segment Information

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company’s operating segments.

The Company has divided its operations into three reportable segments as follows: Contract Manufacturing, Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the fiscal years ended June 30, 2014 and 2013 were $10,970 and $12,264, respectively.

Financial information relating to the fiscal years ended June 30, 2014 and 2013 operations by business segment are as follows:

		Sales, Net						Segment
		U.S.		International				Gross				Capital		Total
		Customers		Customers		Total		Profit		Depreciation		Expenditures		Assets
Contract Manufacturing	2014	$	20,096	$	9,970	$	30,066	$	4,209	$	241	$	255	$	7,752
	2013		18,331		10,978		29,309		4,626		267		94		8,524
Branded Proprietary Products	2014		501		847		1,348		86		2		1		1,781
	2013		1,164		1,118		2,282		346		8		1		2,186
Other Nutraceutical Businesses	2014		2,116		153		2,269		588		9		2		2,050
	2013		1,864		168		2,032		529		13		3		1,901
Total Company	2014		22,713		10,970		33,683		4,883		252		258		11,583
	2013		21,359		12,264		33,623		5,501		288		98		12,611